UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Pharmacokinetics-Pharmacodynamics of Antimicrobial Therapy: It's Not Just for Mice Anymore

Clinical infectious diseases, 2007-01, Vol.44 (1), p.79-86

2007

Volltextzugriff (PDF)

Daptomycin Exposure and the Probability of Elevations in the Creatine Phosphokinase Level: Data from a Randomized Trial of Patients with Bacteremia and Endocarditis

Clinical infectious diseases, 2010-06, Vol.50 (12), p.1568-1574

2010

Volltextzugriff (PDF)

Minimal Physiologically Based Pharmacokinetic and Drug‐Drug‐Disease Interaction Model of Rivaroxaban and Verapamil in Healthy and Renally Impaired Subjects

Journal of clinical pharmacology, 2018-04, Vol.58 (4), p.541-548

2018

Volltextzugriff (PDF)

Evaluation of Daptomycin Exposure and Efficacy and Safety Endpoints To Support Risk-versus-Benefit Considerations

Antimicrobial agents and chemotherapy, 2016-03, Vol.60 (3), p.1600-1607

2016

Volltextzugriff (PDF)

Pharmacological and Patient-Specific Response Determinants in Patients with Hospital-Acquired Pneumonia Treated with Tigecycline

Antimicrobial Agents and Chemotherapy, 2012-02, Vol.56 (2), p.1065-1072

2012

Volltextzugriff (PDF)

Population Pharmacokinetics of Rezafungin in Patients with Fungal Infections

Antimicrobial agents and chemotherapy, 2021-10, Vol.65 (11), p.e0084221

2021

Volltextzugriff (PDF)

Pharmacokinetics-Pharmacodynamics of Tigecycline in Patients with Community-Acquired Pneumonia

Antimicrobial Agents and Chemotherapy, 2012, Vol.56 (1), p.130-136

2012

Volltextzugriff (PDF)

Oritavancin Population Pharmacokinetics in Healthy Subjects and Patients with Complicated Skin and Skin Structure Infections or Bacteremia

Antimicrobial Agents and Chemotherapy, 2009-10, Vol.53 (10), p.4422-4428

2009

Volltextzugriff (PDF)

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Evaluate In Vitro Susceptibility Test Interpretive Criteria for Ceftaroline against Staphylococcus aureus and Streptococcus pneumoniae

Antimicrobial Agents and Chemotherapy, 2014-02, Vol.58 (2), p.885-891

2014

Volltextzugriff (PDF)

Antibacterial Drug Development: A New Approach Is Needed for the Field to Survive and Thrive

Antibiotics (Basel), 2020-07, Vol.9 (7), p.412

2020

Volltextzugriff (PDF)

Tigecycline Population Pharmacokinetics in Patients with Community- or Hospital-Acquired Pneumonia

Antimicrobial Agents and Chemotherapy, 2010-12, Vol.54 (12), p.5180-5186

2010

Volltextzugriff (PDF)

Frequentist and Bayesian Pharmacometric-Based Approaches To Facilitate Critically Needed New Antibiotic Development: Overcoming Lies, Damn Lies, and Statistics

Antimicrobial Agents and Chemotherapy, 2012-03, Vol.56 (3), p.1466-1470

2012

Volltextzugriff (PDF)

Pharmacokinetic/Pharmacodynamic Evaluation of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib for Non-cystic Fibrosis Bronchiectasis

Clinical pharmacokinetics, 2022-10, Vol.61 (10), p.1457-1469

2022

Volltextzugriff (PDF)

Population Pharmacokinetic Analyses for Rezafungin (CD101) Efficacy Using Phase 1 Data

Antimicrobial agents and chemotherapy, 2018-06, Vol.62 (6)

2018

Volltextzugriff (PDF)

Prediction of lefamulin epithelial lining fluid penetration after intravenous and oral administration using Phase 1 data and population pharmacokinetics methods

Journal of antimicrobial chemotherapy, 2019-04, Vol.74 (Supplement_3), p.iii27-iii34

2019

Volltextzugriff (PDF)

Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Vaborbactam and Meropenem Alone and in Combination following Single and Multiple Doses in Healthy Adult Subjects

Antimicrobial agents and chemotherapy, 2018-04, Vol.62 (4)

2018

Volltextzugriff (PDF)

Pharmacokinetic-Pharmacodynamic Analyses for Efficacy of Ceftaroline Fosamil in Patients with Community-Acquired Bacterial Pneumonia

Antimicrobial Agents and Chemotherapy, 2013-12, Vol.57 (12), p.6348-6350

2013

Volltextzugriff (PDF)

Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers

Science translational medicine, 2023-03, Vol.15 (688), p.eadg2783

2023

Volltextzugriff (PDF)

Model-Based Approach for Optimizing Ceftobiprole Dosage in Pediatric Patients

Antimicrobial agents and chemotherapy, 2021-10, Vol.65 (11), p.e0120621-e0120621

2021

Volltextzugriff (PDF)

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae

Antimicrobial agents and chemotherapy, 2023-04, Vol.67 (4), p.e0221321-e0221321

2023

Volltextzugriff (PDF)

Erratum for Lakota et al., "Population Pharmacokinetic Analyses for Rezafungin (CD101) Efficacy Using Phase 1 Data"

Antimicrobial agents and chemotherapy, 2019-04, Vol.63 (4)

2019

Volltextzugriff (PDF)

Assessment of pharmacokinetics-pharmacodynamics to support omadacycline dosing regimens for the treatment of patients with acute bacterial skin and skin structure infections

Antimicrobial agents and chemotherapy, 2024-09, Vol.68 (9)

2024

Volltextzugriff (PDF)

Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata

Antimicrobial agents and chemotherapy, 2018-06, Vol.62 (6)

2018

Volltextzugriff (PDF)

Single-Dose Pharmacokinetics and Safety of Meropenem-Vaborbactam in Subjects with Chronic Renal Impairment

Antimicrobial agents and chemotherapy, 2018-03, Vol.62 (3)

2018

Volltextzugriff (PDF)

Impaired Rivaroxaban Clearance in Mild Renal Insufficiency With Verapamil Coadministration: Potential Implications for Bleeding Risk and Dose Selection

Journal of clinical pharmacology, 2018-04, Vol.58 (4), p.533-540

2018

Volltextzugriff (PDF)

1 – 25 von 173

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(170)
Mit Volltextzugriff
(151)

Publikationsform

Sprache

Englisch
(173)

Erscheinungsjahr

n.n

Thema

Science & Technology
(94)
Life Sciences & Biomedicine
(88)
Humans
(57)
Pharmacology & Pharmacy
(50)
Microbiology
(44)
Female
(36)
Male
(30)
Middle Aged
(27)
Pharmacology
(24)
Adult
(23)
Biological And Medical Sciences
(23)
Medical Sciences
(23)
Pharmacokinetics
(23)
Infectious Diseases
(21)
Aged
(18)
Pharmacology. Drug Treatments
(18)
Anti-Bacterial Agents
(17)
Anti-Bacterial Agents - Pharmacokinetics
(17)
Anti-Bacterial Agents - Therapeutic Use
(17)
Antibiotics. Antiinfectious Agents. Antiparasitic Agents
(16)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 7 Tagen
(1)
... seit 30 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Pharmacokinetics-Pharmacodynamics of Antimicrobial Therapy: It's Not Just for Mice Anymore

Daptomycin Exposure and the Probability of Elevations in the Creatine Phosphokinase Level: Data from a Randomized Trial of Patients with Bacteremia and Endocarditis

Minimal Physiologically Based Pharmacokinetic and Drug‐Drug‐Disease Interaction Model of Rivaroxaban and Verapamil in Healthy and Renally Impaired Subjects

Evaluation of Daptomycin Exposure and Efficacy and Safety Endpoints To Support Risk-versus-Benefit Considerations

Pharmacological and Patient-Specific Response Determinants in Patients with Hospital-Acquired Pneumonia Treated with Tigecycline

Population Pharmacokinetics of Rezafungin in Patients with Fungal Infections

Pharmacokinetics-Pharmacodynamics of Tigecycline in Patients with Community-Acquired Pneumonia

Oritavancin Population Pharmacokinetics in Healthy Subjects and Patients with Complicated Skin and Skin Structure Infections or Bacteremia

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses To Evaluate In Vitro Susceptibility Test Interpretive Criteria for Ceftaroline against Staphylococcus aureus and Streptococcus pneumoniae

Antibacterial Drug Development: A New Approach Is Needed for the Field to Survive and Thrive

Tigecycline Population Pharmacokinetics in Patients with Community- or Hospital-Acquired Pneumonia

Frequentist and Bayesian Pharmacometric-Based Approaches To Facilitate Critically Needed New Antibiotic Development: Overcoming Lies, Damn Lies, and Statistics

Pharmacokinetic/Pharmacodynamic Evaluation of the Dipeptidyl Peptidase 1 Inhibitor Brensocatib for Non-cystic Fibrosis Bronchiectasis

Population Pharmacokinetic Analyses for Rezafungin (CD101) Efficacy Using Phase 1 Data

Prediction of lefamulin epithelial lining fluid penetration after intravenous and oral administration using Phase 1 data and population pharmacokinetics methods

Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Vaborbactam and Meropenem Alone and in Combination following Single and Multiple Doses in Healthy Adult Subjects

Pharmacokinetic-Pharmacodynamic Analyses for Efficacy of Ceftaroline Fosamil in Patients with Community-Acquired Bacterial Pneumonia

Antibody-mediated protection against symptomatic COVID-19 can be achieved at low serum neutralizing titers

Model-Based Approach for Optimizing Ceftobiprole Dosage in Pediatric Patients

Pharmacokinetic-Pharmacodynamic Target Attainment Analyses Evaluating Omadacycline Dosing Regimens for the Treatment of Patients with Community-Acquired Bacterial Pneumonia Arising from Streptococcus pneumoniae and Haemophilus influenzae

Erratum for Lakota et al., "Population Pharmacokinetic Analyses for Rezafungin (CD101) Efficacy Using Phase 1 Data"

Assessment of pharmacokinetics-pharmacodynamics to support omadacycline dosing regimens for the treatment of patients with acute bacterial skin and skin structure infections

Overcoming the Resistance Hurdle: Pharmacokinetic-Pharmacodynamic Target Attainment Analyses for Rezafungin (CD101) against Candida albicans and Candida glabrata

Single-Dose Pharmacokinetics and Safety of Meropenem-Vaborbactam in Subjects with Chronic Renal Impairment

Impaired Rivaroxaban Clearance in Mild Renal Insufficiency With Verapamil Coadministration: Potential Implications for Bleeding Risk and Dose Selection

Suchergebnisse filtern